Cargando…
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic has had unprecedented impact on the provision of medical care for genetic disorders. The purpose of this study was to assess the effects of the pandemic on neurofibromatosis (NF) care and research. METHODS: Sixty-three United States NF clinic...
Autores principales: | Radtke, Heather B., Klein-Tasman, Bonita P., Merker, Vanessa L., Knight, Pamela, Ullrich, Nicole J., Jordan, Justin T., Korf, Bruce, Plotkin, Scott R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848872/ https://www.ncbi.nlm.nih.gov/pubmed/33522938 http://dx.doi.org/10.1186/s13023-021-01711-w |
Ejemplares similares
-
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
por: Merker, Vanessa L., et al.
Publicado: (2022) -
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis
por: Merker, Vanessa L., et al.
Publicado: (2018) -
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
por: Klesse, Laura J., et al.
Publicado: (2020) -
Psychometric Properties of Attention Measures in Young Children with Neurofibromatosis Type 1: Preliminary Findings
por: Pardej, Sara K., et al.
Publicado: (2022) -
Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study
por: Seidlin, Mindell, et al.
Publicado: (2017)